oligometastatic non-small cell lung cancer;
metastatic non-small cell lung cancer;
NSCLC history;
lung cancer staging;
surgery and NSCLC;
local consolidative therapy (LCT);
locally-aggressive therapy (LAT);
LONG-TERM SURVIVAL;
PROGNOSTIC-FACTORS;
THERAPY;
RADIOTHERAPY;
CLASSIFICATION;
MULTICENTER;
PROGRESSION;
METASTASIS;
MANAGEMENT;
RESECTION;
D O I:
10.3390/cancers14102524
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Simple Summary This article clarifies the context and definition of the term oligometastasis as it applies to non-small cell lung cancer and reviews the current results in the use of surgery for its management. Ideally after reading this article, practitioners will be better equipped to pick patients for locally aggressive therapy, and researchers will be primed to design the next generation of studies that prioritize treatments in the management of this historically deadly disease. Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited number of metastatic sites. It is analogous to an intermediate stage of NSCLC, between localized and widely metastatic disease, even though no staging criteria establishes this distinction. Oligometastatic NSCLC describes a patient subgroup with limited metastasis to one or a few organs. These patients seem to have a more indolent cancer than those with diffuse metastasis. For these select patients with oligometastatic disease, the use of palliative systemic therapy over local aggressive treatment may be a missed opportunity to improve survival. The clear definition of this subgroup and identification of the best treatment remains the current challenge in the management of the disease. Surgery was the early cornerstone in the treatment of limited disease; however, as modalities such as chemotherapy, stereotactic radiosurgery, and immunotherapy have matured, the role of excision is less clearly defined. There are sparse randomized controlled trials comparing the efficacy of different treatment modalities in patients with oligometastatic NSCLC. However, there is a growing body of retrospective research detailing the prognostic factors that characterize the role of surgery in the management of these patients. This article clarifies the context and definition of the term oligometastatic, as it applies to NSCLC, and reviews the current results in the use of surgery for its management.
机构:
Univ Hosp La Fe, Dept Med Oncol, Ave Fernando Abril Martorell 106, Valencia 46026, SpainUniv Hosp La Fe, Dept Med Oncol, Ave Fernando Abril Martorell 106, Valencia 46026, Spain
Juan, Oscar
Popat, Sanjay
论文数: 0引用数: 0
h-index: 0
机构:
Royal Marsden Hosp, Lung Unit, London, England
Imperial Coll London, Fac Med, Natl Heart & Lung Inst, London, England
Inst Canc Res, London, EnglandUniv Hosp La Fe, Dept Med Oncol, Ave Fernando Abril Martorell 106, Valencia 46026, Spain